T. Rowe Price Associates’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$267M Sell
5,525,745
-5,511,133
-50% -$266M 0.03% 377
2025
Q1
$612M Buy
11,036,878
+193,196
+2% +$10.7M 0.08% 241
2024
Q4
$523M Buy
10,843,682
+5,091,304
+89% +$246M 0.06% 259
2024
Q3
$332M Buy
5,752,378
+3,890,678
+209% +$224M 0.04% 346
2024
Q2
$90.3M Buy
1,861,700
+536,838
+41% +$26M 0.01% 568
2024
Q1
$64.4M Sell
1,324,862
-32,835
-2% -$1.6M 0.01% 655
2023
Q4
$67.5M Buy
1,357,697
+14,358
+1% +$714K 0.01% 619
2023
Q3
$72.1M Sell
1,343,339
-35,589
-3% -$1.91M 0.01% 578
2023
Q2
$74.3M Sell
1,378,928
-664,489
-33% -$35.8M 0.01% 591
2023
Q1
$111M Sell
2,043,417
-833,389
-29% -$45.4M 0.02% 491
2022
Q4
$139M Sell
2,876,806
-9,420,070
-77% -$456M 0.02% 437
2022
Q3
$472M Sell
12,296,876
-4,947,478
-29% -$190M 0.08% 234
2022
Q2
$863M Buy
17,244,354
+10,684,509
+163% +$535M 0.11% 199
2022
Q1
$337M Buy
6,559,845
+417,741
+7% +$21.4M 0.03% 405
2021
Q4
$308M Buy
6,142,104
+529,723
+9% +$26.5M 0.03% 445
2021
Q3
$271M Buy
5,612,381
+1,229,367
+28% +$59.3M 0.03% 462
2021
Q2
$231M Sell
4,383,014
-1,642
-0% -$86.5K 0.02% 523
2021
Q1
$217M Buy
4,384,656
+1,376,204
+46% +$68.1M 0.02% 531
2020
Q4
$146M Buy
3,008,452
+1,593,595
+113% +$77.2M 0.02% 606
2020
Q3
$71M Buy
1,414,857
+165,341
+13% +$8.3M 0.01% 760
2020
Q2
$63.8M Buy
+1,249,516
New +$63.8M 0.01% 769
2014
Q1
Sell
-5,000
Closed -$268K 2513
2013
Q4
$268K Buy
+5,000
New +$268K ﹤0.01% 2193